Literature DB >> 22581943

Tobacco consumption in Mozambique: use of distinct types of tobacco across urban and rural settings.

Patrícia Padrão1, Albertino Damasceno, Carla Silva-Matos, Helena Carreira, Nuno Lunet.   

Abstract

INTRODUCTION: Monitoring tobacco consumption patterns is essential to define and evaluate strategies to control the tobacco epidemic. We aimed to quantify the use of smoked (manufactured/hand-rolled cigarettes) and smokeless (snuff/chew) tobacco, according to sociodemographic characteristics, in adult Mozambicans.
METHODS: A national representative sample (n = 3,323) of subjects aged 25-64 years was evaluated in 2005 following the World Health Organization Stepwise Approach to Chronic Disease Risk Factor Surveillance (STEPS), which included the assessment of tobacco consumption with the quantification of each type of tobacco used daily. We computed prevalences, and age- and education-adjusted prevalence ratios (PRs), with 95% CIs.
RESULTS: Daily smoking was reported by 9.1% (95% CI = 5.0-13.1) of women (manufactured, 3.4%; hand-rolled, 5.6%) and 33.6% (95% CI = 29.3-38.0) of men (manufactured, 18.7%; hand-rolled, 14.8%). Daily manufactured cigarette smoking was significantly more frequent in men (urban: PR = 14.62, 95% CI = 7.59-28.55; rural: PR = 4.32, 95% CI = 2.42-7.71). Daily hand-rolled cigarette smoking was three- to fourfold more frequent among men and nearly 80% less frequent in urban areas, regardless of sex. The prevalence of daily smokeless tobacco use was 7.4% (95% CI = 4.6-10.2) in women (chew, 6.4%; snuff, 1.0%) and 3.4% (95% CI = 1.7-5.2) in men (chew, 1.6%; snuff, 1.8%). Daily smokeless tobacco consumption was significantly less frequent in urban areas only among men (PR = 0.05, 95% CI = 0.01-0.33).
CONCLUSIONS: Despite the relatively low levels of manufactured cigarette smoking, traditional forms of tobacco consumption are frequent, especially among women and in rural settings, showing the need for control measures to target specifically different patterns of consumption.

Entities:  

Mesh:

Year:  2012        PMID: 22581943     DOI: 10.1093/ntr/nts111

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  7 in total

1.  Cardiovascular risk in Mozambique: who should be treated for hypertension?

Authors:  Albertino Damasceno; Patrícia Padrão; Carla Silva-Matos; António Prista; Ana Azevedo; Nuno Lunet
Journal:  J Hypertens       Date:  2013-12       Impact factor: 4.844

2.  Prevalence, distribution, and social determinants of tobacco use in 30 sub-Saharan African countries.

Authors:  Chandrashekhar T Sreeramareddy; Pranil Mansingh Pradhan; Shwe Sin
Journal:  BMC Med       Date:  2014-12-18       Impact factor: 8.775

3.  Tobacco consumption and nicotine dependence in Bengo Province, Angola: A community-based survey.

Authors:  João M Pedro; Miguel Brito; Henrique Barros
Journal:  PLoS One       Date:  2017-11-27       Impact factor: 3.240

4.  Risk factors for oesophageal squamous cell carcinoma in Mozambique.

Authors:  Lina Cunha; Filipa Fontes; Jotamo Come; Vitória Lobo; Lúcio Lara Santos; Nuno Lunet; Carla Carrilho
Journal:  Ecancermedicalscience       Date:  2022-08-04

5.  Tobacco consumption and positive mental health: an epidemiological study from a positive psychology perspective.

Authors:  Juan Carlos Bazo-Alvarez; Frank Peralta-Alvarez; Antonio Bernabé-Ortiz; Germán F Alvarado; J Jaime Miranda
Journal:  BMC Psychol       Date:  2016-05-04

6.  The Political Economy of Tobacco in Mozambique and Zimbabwe: A Triangulation Mixed Methods Protocol.

Authors:  Raphael Lencucha; Jeffrey Drope; Ronald Labonte; Benedito Cunguara; Arne Ruckert; Zvikie Mlambo; Artwell Kadungure; Stella Bialous; Nhamo Nhamo
Journal:  Int J Environ Res Public Health       Date:  2020-06-15       Impact factor: 3.390

7.  Reducing the Number of People with Dementia Through Primary Prevention in Mozambique, Brazil, and Portugal: An Analysis of Population-Based Data.

Authors:  Deborah Oliveira; Leonardo Jun Otuyama; Dirceu Mabunda; Flavio Mandlate; Manuel Gonçalves-Pereira; Miguel Xavier; Jerson Laks; Cleusa P Ferri
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.